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Abstract
Gastrointestinal stromal tumours are rare mesenchymal neoplasms affecting the digestive tract or
nearby structures within the abdomen. We present a case of a 66-year-old female patient who
presented with obscure anemia due to gastrointestinal bleeding and underwent exploratory
laparotomy during which a large gastrointestinal stromal tumour of the small intestine was
discovered. Examining the preoperative results of video capsule endoscopy, computed tomography,
and angiography and comparing them with the operative findings we discuss which of these
investigations plays the most important role in the detection and localization of gastrointestinal
stromal tumours. A sort review of the literature is also conducted on these rare mesenchymal
tumours.
Introduction
Gastrointestinal stromal tumours (GISTs), which arise
primarily in the gut wall, are uncommon mesenchymal,
malignant or potentially malignant tumours affecting
the gastrointestinal tract. GISTs are the most common
non epithelial tumors of the digestive tract, accounting
for only 1% of all gastrointestinal malignancies [1,2] and
for 5.7% of all sarcomas [3]. These tumours are defined
as specific, generally Kit (CD117)-positive and Kit or
platelet-derived growth factor receptor alpha (PDGFRA)
mutation-driven tumours [4].
This paper reports a case of obscure gastrointestinal
bleeding due to a large GIST of the jejunum evaluates
the role of preoperative investigations of this association
and provides a short English literature review.
Case presentation
A 66-year-old Caucasian female with no past medical
history presented with a 3-month history of anemia. There
was no associated fever, dyspeptic symptoms, nausea,
weight loss, vomiting, or localized abdominal pain.
Physical examination and blood biochemistry were within
normal rates. Hematologic tests showed decrease of
hematocrit (Ht: 19%) and platelets (PLT) count of
76,000/mL. The patient was HIV 1-2 negative. CEA and
CA 19-9 were in the normal range.
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(US), upper gastrointestinal endoscopy, and colonoscopy
were unremarkable. Abdominal computed tomography
(CT) showed a well-delimited lobulated large mass
measuring 10 ¥ 9 ¥ 5 cm in the jejunum with malignant
behavior. Video capsule endoscopy (VCE) revealed an
extensive venous plexus giving the possible diagnosis of
angiodysplasia of small intestine. Angiography demon-
strated voluminous disorder with abnormal arterial
structures and areas of stagnation of the contrast medium
(Figures 1,2). Due to the extension of the disorder, the
embolization was abandoned.
The patient underwent exploratory laparotomy. During
surgery, a well-circumscribed lesion, measuring
10.5 ¥ 9.5 ¥ 6 cm was identified at the jejunum (Figure 3).
A complete resection of the mass and a side to side
anastomosisofthesmallbowelwereperformed.Thepatient
had an uneventful postoperative course and was discharged
on the sixth postoperative day.
The histopathological examination of the resected lesion
revealed a mesenchymal tumour categorized as GIST
tumour.Thestromaltumourdemonstratedwhirlingsheets
of spindle cells with moderate level of phenomorphism
and mitotic activity (6-7 mitoses/50 HPF) (H&E stain).
No necrosis was observed. Immunohistochemical staining
for CD117, a-smooth-muscle actin (SMA), and S-100
protein was positive, whereas staining for desmin and
CD34 was negative. The labeling index for MIB-1,
determined by counting positively stained nuclei, was
about 5%.
Discussion
The term GIST was introduced by Mazur and Clark in 1983
in order to indicate a distinct heterogeneous group of
Figure 1. The superselective catheterization of an ileal
artery shows voluminous disorder with abnormal arterial
structures and areas of stagnation of the contrast medium.
Figure 2. The parenchymal phase of the superselective
catheterization of the same ileal artery shows the full
extent of the disorder.
Figure 3. The well-circumscribed lesion of the jejunum
before its removal.
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varying differentiation [5]. GISTs account for only 1-3% of
gastric tumours, 20% of small bowel tumours, and 1% or
less of colorectal tumours. They have a predilection for
adults older than 50 years, with the median ages varying
around 60 years. Although these tumours usually develop
in a sporadic fashion, familiar occurrence has also been
reported [6].
Random genetic mutations are the apparent cause of
GISTs. The majority of these tumours show identified
mutations in cell-surface proteins called tyrosine kinase
receptors [4]. Most GISTs show mutations in a gene that
produces a growth factor receptor called KIT [6].
Primary GISTs may occur anywhere along the GI tract from
the esophagus to the anus [7]. The most frequent site is the
stomach (55%), followed by the duodenum and small
intestine (30%), esophagus (5%), rectum (5%), colon
(2%), and rare other locations.
The most common presentation of GIST is acute or
chronic gastrointestinal bleeding. They often present with
nausea, vomiting, abdominal pain, metastatic diseases,
and bowel obstruction. However, the symptoms depend
on GIST location and size. Many tumours are found
incidentally through medical imaging for other purposes
or through surgery for other conditions. In our case, the
patient presented with anemia due to obscure bleeding.
Many studies emphasize the CD117 and CD 34 expression
in GISTs [8]. A method of measuring of how fast a GIST is
growing is by the mitotic count visual examination of a set
number of ‘high power fields’ (HPF) under the microscope
to count the number of tumour cells caught in the process
of mitosis or cell division. The higher the mitotic count,
the faster the tumor is growing. In this reported case, GIST
was diagnosed as a malignancy with moderate level of
phenomorphism and mitotic activity while immunohis-
tochemical staining for CD117, SMA, and S-100 protein
was positive.
The treatment of choice is the complete resection of the
tumour. The surgeon’s approach in an actual case depends
on factors such as: the exact anatomical site of the GIST,
the characteristics of the individual patient’s particular
situation, the specific location of the tumour relative to the
blood supply of the involved organ, and the patient’s
condition. Patients with unresectable tumours or with
metastatic disease are treated with Kit/PDGFRA tyrosine
kinase inhibitors. Metastases may develop in the liver and
the abdominal membranes. Patients with advanced GISTs
which progress rapidly and result in organ destruction
have poor prognosis.
In this reported case, the used diagnostic tools were
abdominal US, upper gastrointestinal endoscopy, colono-
scopy, abdominal CT, VCE and angiography. The first
three investigations were unremarkable due the location of
the tumour. The abdominal CT correctly imaged the
location and the size of the tumour. It also excluded liver
or peritoneal metastases and evaluated the extension of
the primary tumour. However, CT did not establish the
histological diagnosis of GIST. It is known that as most
GISTs have an exophytic growth, CT imaging is more
useful than endoscopy and barium studies to evaluate the
extension and the size of the tumour [9]. It is also sensitive
for the detection of metastatic lesions [10]. Lupescu et al
[11] reported that using the CT we can only suspect the
diagnosis to GISTs. They refer that it is difficult to
differentiate, using only CT imaging, this type of tumours
from other soft-tissue ones. Finally, Wu et al in a series of
100 small intestine GISTs refer that the sensitivity rate of
abdominal CT was 91% [12].
VCE revealed an extensive venous plexus giving the
possible diagnosis of angiodysplasia of small intestine in
our patient. This investigation did not establish the
diagnosis of tumour referring simply a benign abnorm-
ality. VCE did not help the diagnosis in our case. In 29
centres of 10 European countries, 5129 patients under-
went VCE. 124 (2.4%) of them had small bowel tumours
[13]. The most common indication for VCE was obscure
gastrointestinal bleeding (108 patients) while the main
primary small bowel tumour type was GIST (32%). These
data suggested that VCE detected small-bowel tumours in
a small proportion of patients underwent this examina-
tion. However, the early use of this diagnostic tool could
shorten the diagnostic work-up and influenced the
subsequent management of these patients [13]. Ziegler
et al [14] reported that VCE identified small intestine
lesions generally beyond the reach of push enteroscopy in
25% to 50% of patients and revealed additional diagnostic
findings in 25% of patients compared with small bowel
barium radiographic studies. The authors conclude that in
some cases, the information provided by VCE in patients
with obscure gastrointestinal bleeding can lead to changes
in management that would improve their outcome.
However, we did not use push enteroscopy and small
intestine barium radiographic studies so we have not the
ability to compare the results among these diagnostic
tools.
In this reported case, angiography showed voluminous
disorder with abnormal arterial structures and areas of
stagnation of the contrast medium giving the diagnosis of
a hypervascular malignant tumour without establishing
the histological diagnosis of GIST. Despite there are not
many studies regarding the use of VCE in diagnosis of
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differentiate benign from malignant tumours, define
their size, range and origin, despite the exophytic or
endophytic growth of the tumours. However, they do not
suggest routine use of VCE because of its risk and relative
complications.
In conclusion, abdominal CT, VCE, and angiography were
the diagnostic approaches we used for the GIST in our case
report. It is known that the sensitivity of these investiga-
tions varied according to the location of the tumour. We
found that CT was the most effective diagnostic method
and we suggest routine use of this procedure in opposition
to VCE and angiography which can give us some
information but can also lead to changes in management
that would not improve patient’s outcome.
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